Stock earnings page

IQIYI INC (IQ)

Track the next or latest earnings date for IQIYI INC, review consensus estimates, and see cached AI analysis for recent quarterly results.

View this earnings week Open in the app

Recent earnings news

The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
GlobeNewswire · 2026-05-22T15:30:00Z

Issued on behalf of Conexeu Sciences Inc.A biotech debut out of Reno is betting that the next wave of medicine won’t replace tissue — it’ll grow it back.NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- Energy Metal News News Commentary — Somewhere between a 3D prin…

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
PRNewswire · 2026-05-22T14:31:00Z

Issued on behalf of Conexeu Sciences Inc. Companies mentioned: Conexeu Sciences Inc. (NASDAQ: CNXU), Integra LifeSciences Holdings Corporation (NASDAQ: IART), Evolus, Inc. (NASDAQ: EOLS), Bioventus Inc. (NASDAQ: BVS), Mesoblast Limited (NASDAQ: MESO) KEY TAKE…

SpaceX IPO Set to Lift the Whole Space Sector -- And One NYSE American Operator Just Stepped Into a Capability NASA Has Asked Industry to Rebuild
PRNewswire · 2026-05-22T14:19:00Z

Issued on behalf of Starfighters Space, Inc. USA News Group News Commentary — CAPE CANAVERAL, Fla., May 22, 2026 /PRNewswire/ -- Key Takeaways: A Yahoo Finance segment yesterday laid out how the looming SpaceX IPO is set to act as "rocket fuel" for space ETFs…

A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching
GlobeNewswire · 2026-05-22T14:09:00Z

Issued on behalf of Conexeu Sciences Inc. Issued on behalf of Conexeu Sciences Inc.

CAE reports fourth quarter and full fiscal year 2026 results and targets significant cost savings and profitability growth as part of transformation plan
PRNewswire · 2026-05-21T20:05:00Z

Fourth quarter FY2026 revenue of $1,326.7 million, diluted EPS of $0.23 and adjusted EPS(1) of $0.42 Full-year FY2026 revenue of $4.9 billion, diluted EPS of $0.97 and adjusted EPS of $1.20 Transformation plan targeting $125 million to $150 million annual tra…

Upcoming earnings date

Aug 19, 2026

Time not specified

Fiscal quarter: 2026-06-30

EPS estimate: -$0.09

Revenue estimate: N/A

Market cap: N/A

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week

Date	Quarter	Report window	EPS est.	Revenue est.
Aug 19, 2026	2026-06-30	Time not specified	-$0.09	N/A
Feb 26, 2026	2025-12-31	Pre-market	-$0.01	N/A